{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The three PD-linked ␣S mutations are associated with early-onset autosomal dominant Parkinsonism. ␣S function is linked to its ability to bind synaptic vesicles and undergo conformational reorganization.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the disease mechanism involving ␣S mutations and their role in Parkinsonism, as well as the functional relevance of conformational changes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Pulsed dipolar ESR measurements were used to study conformational transitions of ␣S mutants between broken and extended helix states.",
          "judgment": "Yes",
          "reasoning": "The assay directly examines conformational changes in ␣S, which are central to its normal function and disease-related aggregation. This aligns with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compared three ␣S mutants to wild-type ␣S but does not explicitly mention the use of null or other variant controls. Replicates are implied through the analysis of three variants.",
          "judgment": "Yes",
          "reasoning": "Wild-type ␣S serves as a functional control, but no explicit mention of replicates or additional variant controls is provided.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The study does not use known pathogenic or benign variants as controls. Analysis is limited to the three mutants and wild-type ␣S.",
          "judgment": "No",
          "reasoning": "No variant controls (e.g., previously classified pathogenic/benign) are used to validate the assay's specificity for the three mutants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper does not provide statistical tests, p-values, or OddsPath calculations for the functional data.",
          "judgment": "No",
          "reasoning": "Lack of statistical analysis prevents estimation of OddsPath for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: Total benign/pathogenic variant controls",
          "extracted_paper_info": "Only the three PD-linked mutants are analyzed. No additional controls are used.",
          "judgment": "10 or less",
          "reasoning": "The study includes only three variants (three mutants) and no external controls, totaling fewer than 10 comparisons.",
          "next_step_or_outcome": "Functional evidence strength: Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The three PD-linked ␣S mutations are associated with early-onset autosomal dominant Parkinsonism. ␣S function is linked to its ability to bind synaptic vesicles and undergo conformational reorganization.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the disease mechanism involving ␣S mutations and their role in Parkinsonism, as well as the functional relevance of conformational changes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Pulsed dipolar ESR measurements were used to study conformational transitions of ␣S mutants between broken and extended helix states.",
          "judgment": "Yes",
          "reasoning": "The assay directly examines conformational changes in ␣S, which are central to its normal function and disease-related aggregation. This aligns with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compared three ␣S mutants to wild-type ␣S but does not explicitly mention the use of null or other variant controls. Replicates are implied through the analysis of three variants.",
          "judgment": "Yes",
          "reasoning": "Wild-type ␣S serves as a functional control, but no explicit mention of replicates or additional variant controls is provided.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The study does not use known pathogenic or benign variants as controls. Analysis is limited to the three mutants and wild-type ␣S.",
          "judgment": "No",
          "reasoning": "No variant controls (e.g., previously classified pathogenic/benign) are used to validate the assay's specificity for the three mutants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper does not provide statistical tests, p-values, or OddsPath calculations for the functional data.",
          "judgment": "No",
          "reasoning": "Lack of statistical analysis prevents estimation of OddsPath for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: Total benign/pathogenic variant controls",
          "extracted_paper_info": "Only the three PD-linked mutants are analyzed. No additional controls are used.",
          "judgment": "10 or less",
          "reasoning": "The study includes only three variants (three mutants) and no external controls, totaling fewer than 10 comparisons.",
          "next_step_or_outcome": "Functional evidence strength: Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The three PD-linked ␣S mutations are associated with early-onset autosomal dominant Parkinsonism. ␣S function is linked to its ability to bind synaptic vesicles and undergo conformational reorganization.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the disease mechanism involving ␣S mutations and their role in Parkinsonism, as well as the functional relevance of conformational changes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Pulsed dipolar ESR measurements were used to study conformational transitions of ␣S mutants between broken and extended helix states.",
          "judgment": "Yes",
          "reasoning": "The assay directly examines conformational changes in ␣S, which are central to its normal function and disease-related aggregation. This aligns with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compared three ␣S mutants to wild-type ␣S but does not explicitly mention the use of null or other variant controls. Replicates are implied through the analysis of three variants.",
          "judgment": "Yes",
          "reasoning": "Wild-type ␣S serves as a functional control, but no explicit mention of replicates or additional variant controls is provided.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The study does not use known pathogenic or benign variants as controls. Analysis is limited to the three mutants and wild-type ␣S.",
          "judgment": "No",
          "reasoning": "No variant controls (e.g., previously classified pathogenic/benign) are used to validate the assay's specificity for the three mutants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper does not provide statistical tests, p-values, or OddsPath calculations for the functional data.",
          "judgment": "No",
          "reasoning": "Lack of statistical analysis prevents estimation of OddsPath for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: Total benign/pathogenic variant controls",
          "extracted_paper_info": "Only the three PD-linked mutants are analyzed. No additional controls are used.",
          "judgment": "10 or less",
          "reasoning": "The study includes only three variants (three mutants) and no external controls, totaling fewer than 10 comparisons.",
          "next_step_or_outcome": "Functional evidence strength: Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    }
  ]
}